4.7 Article

Functional validation of the albinism-associated tyrosinase T373K SNP by CRISPR/Cas9-mediated homology-directed repair (HDR) in rabbits

期刊

EBIOMEDICINE
卷 36, 期 -, 页码 517-525

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ebiom.2018.09.041

关键词

Tyrosinase; OCA; T373K; Point mutation; Rabbit; CRISPR/Cas9

资金

  1. National Key Research and Development Program of China Stem Cell and Translational Research [2017YFA0105101]
  2. Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16030501, XDA16030503]
  3. Guangdong Province Science and Technology Plan Project [2014B020225003]
  4. Program for JLU Science and Technology Innovative Research Team [2017TD-28]

向作者/读者索取更多资源

Background: Oculocutaneous albinism (OCA) is a group of autosomal recessive disorders characterized by reduced melanin that are caused by mutations in the gene encoding tyrosinase (TYR), which is the rate-limiting enzyme in the production of the pigment melanin. Many studies or meta-analyses have suggested an association between the TYR T373KSNP and OCA1, but there is limited biochemical and genetic evidence to support this association. Methods: We overexpressed TYR-WT and TYR-T373K mutants on HK293T cells and tested the changes of melanin production and tyrosinase activity. Then we generated TYR-K373T knock-in (KO rabbits by microinjection of ssDNA and synthesized RNAs targeting C1118A using CRISPR/Cas9-HDR to observe the formation of melanin. Findings: We demonstrated that the T373K mutation in TYR can reduce tyrosinase activity, leading to an absence of melanin synthesis at the cell-level. The gene-edited TYR-K373T rabbits exhibited rescued melanin production in hair follicles and irises, as inferred from the evident decrease in pigmentation in TYR-T373K rabbits, thus providing functional validation of the albinism-associated T373K SNP at the animal level. interpretation: Our study provides the first animal-level functional validation of the albinism-associated TYR K373T SNP in rabbits, and these results will facilitate gene therapy of OCA1 in pre-clinical settings in the future. (C) 2018 Published by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据